
ã¡ã¬ãã ! éºäŒåçµã¿æãå¯çè«ã¯mRNAãã¯ã¿ãŒã§ãã
2022幎10æ16æ¥
Dr.ã¢ãªã€ãã»ã©ãïŒN.D.)
å èšäºã¯ãã¡ãã
æªã®æ¯é è ã¯ããšã¢ããŸã«åããçåæAiããå µåšãã¹ãã€ã¯ã¿ã³ãã¯ããéœåžãçºã«æ£åžããå°çåžæ°ãææã«é¥ããŸãã- ã«ã¬ã³ã»ãã³ã°ã¹ãã³
ã¢ãªã€ãã»ã©ãå士
æè¿ãç§ã¯äŒèª¬ã®ãããŒãã»Oã»ã€ã³ã°å士ãšããŒã ãçµã¿ãCOVID-19ã¯ã¯ãã³ã®mRNAãã¯ã¿ãŒã«ã€ããŠå€§ãã ã·ã§ã«ãå ¬éããŸããã
ã€ã³ã°å士ã¯ã40幎以äžã«ããã£ãŠç¹æ®ãªå®éšè£ 眮ã§äœæ¶²ãåæããŠããäžçŽç§åŠç ç©¶è ã§ããèªç¶çæ³å»ã®2äžã§ã13幎ã®ããã©ã³ã»ãžã£ãŒããªã¹ãã§ããç ç©¶è ã§ããããŸããç§ãšåãããã«ãã€ã³ã°å士ãç®æšãšãã人ç©ã§ããã
1996幎ã«çã®æ²»çæ³ã確ç«ããåŸãã«ã·ãã§ã«ã®é°è¬å£ããæ»æãåãã以æ¥ãå士ã®åãæ±ãããšã«å·å¿µãçãããŠãããç§ã¯2017幎以æ¥ãã€ãºã©ãšã«åœå®¶ã®æšçãšãªãã圌ãã¯ã人皮差å¥ãã®éé£ã§ç§ã®å声ãäžå·ããããšå¿ æ»ã«ãªã£ãŠããŸãã
ã€ã³ã°å士ãšç§ã¯ãå»åŠãšãæ¯ç©äžæ¯ãæªæããèªå·±æ²»çããããã®èº«äœã·ã¹ãã ã®ä»çµã¿ã«ã€ããŠãåãèŠè§£ãå ±æããŠããŸããããã§ç§ãã¡ã¯ãç æ°ã®æ ¹æ¬çãªåå ã«ã€ããŠè©±ãåããã€ã³ã°å士ãäžçäžã®ã¯ã©ã€ã¢ã³ãã«èŠãŠããå¯çè«ã®èå»¶ãåãäžããããšã«ããã®ã§ããã€ã³ã°å士ã¯ããããŸã§ã®ãã£ãªã¢ã§èŠãããšã®ãªããããªãåäŸã®ãªãå¯çè«ã®èå»¶ã«ã€ããŠããŸããšãããããªèšŒæ ã瀺ããŠããŸããVAXXã«ææãã人ãšããã§ãªã人ã®è¡æ¶²ã®90%ã«å¯çè«ãèŠãããããã«ãªã£ããšããã®ã§ãã
ã芧ãã ããã
ç
æ°ã®æ ¹æ¬çãªåå ãšéºäŒåçµã¿æãå¯çè«ã«é¢ããããŒã1ã
ãããŒãã»ã€ã³ã°å士ãšã¢ãªã€ãã»ã©ãå士ïŒ"ç
æ°ã®æ ¹æ¬åå ïŒéºäŒåçµã¿æãå¯çè«"
ç¶ããŠãéºäŒåçµã¿æãå¯çè«ã§ããã¡ãã»ã³ãžã£ãŒRNAãã¯ã¿ãŒã®ç¹èš±å¯©æ»ã«ã€ããŠã2åç®ã®æŸéãè¡ããŸããã
ãã®éºäŒåçµã¿æãå¯çè«ã¯ãã¢ããããã¡ã€ã¶ãŒãããããã¯ã¹ãã€ã³ã»ã³ïŒJ&JïŒããªãã¯ã¹ãã©ãŒããªã©ããããã²ãã ã倿ããŠäººéãåæçç©åŠã«ããããã«äœ¿ã£ãŠãããèŽåœçãªåæçç©åŠã®mRNAãã¯ã¿ãŒãªã®ã ããã§ãããã®éãã補è¬äŒç€Ÿã¯ä»ãCOVIDãã¯ã¯ãã³æ¥çš®ãã«ãã£ãŠäººå·¥çãªéºäŒåé
åãããã²ãã ã«éã蟌ãããã®mRNAãã¯ã¿ãŒãšããŠãèŽåœçãªå¯çè«ã䜿ã£ãŠããã®ã§ãã
èŠãŠãã ããïŒMEGA BOMBS! èŽåœçãªéºäŒåçµã¿æãå¯çè«ãmRNAã®ãã¯ã¿ãŒã«ã
ã€ã³ã°å士ãšã©ãå士ã®ç¹èš±ã¬ãã¥ãŒ
9æ28æ¥ã®æã
ã®å€§çºèŠä»¥æ¥ããã¡ã€ã¶ãŒã®å
éšåçºè
ã§ããç¹èš±å°éå®¶ã§ããã«ã¬ã³ã»ãã³ã°ã¹ãã³ã¯ãã¹ãã¥ã¯ãŒãã¹ã»ã·ã§ãŒã§ãããªãç匟æ
å ±ãéåŒã«èªã£ãŠãããã
圌女ã¯ã人é¡ã«å¯Ÿãããã®çç©åŠçæ»æã®ãã¹ãŠã®åŽé¢ãéåŒã«çµã³ã€ããmRNAãã¯ã¿ãŒãšããŠã®éºäŒåçµã¿æãå¯çè«ãã人éãAIã«æ¥ç¶ãããæå³ã§äœãããããšãæããã«ããã®ã§ãã
ã¡ãªã¿ã«ãã«ã¬ã³ã»ãã³ã°ã¹ãã³ãæšçã«ãªã£ãŠãã人ç©ã§ããã
PART1ïŒã³ãããã¯å¯çè«ã§ããããšã®èšŒæïŒãã€ãªãã¯ãããžãŒã¢ããªã¹ãã¯ã³ããããšãŽã¡ã¯ã·ã¹ã¯çåæå¯çè«ã§ããããšã蚌æããã
ã«ã¬ã³ã»ãã³ã°ã¹ãã³ on Stew Peters Show - Part 1
ããŒã2ïŒã³ãããã¯ããå
µåšãã©ãµã€ãã§ããããšã®èšŒæïŒãã€ãªãã¯ãããžãŒã»ã¢ããªã¹ãã¯ã³ããããšãŽã¡ã¯ã·ã¹ã¯çåæãã©ãµã€ãã§ããããšã®èšŒæãããã
ãã®çç©åŠçæ»æã«é¢ããè¡æçãªèšŒæ ã«ã€ããŠã¯ãKaren Kingstonã®ä»éèšäºãã芧ãã ããã
ããŒã1: COVID-19ã¹ããŒãªãŒã®æ¬ºçãè§£ãæããã
SEQ ID NO: 1ããã³SEQ ID NO: 2
ã³ããã»ã©ã ã«å«ãŸããSEQ ID NOã¯äœçŸããããããã§ã¯ãæåã®2ã€ã ããæ€èšŒããããšã«ããã
SEQ ID NO: 1ã¯ããã«ïŒã¡ãªã³ãã»ã²ã€ããææããPirbright Instituteãç¹èš±ãååŸããææããŠããŸããããã¯ããªãããããŸãã¯ã¢ããé žé åãå«ãã§ããŸãããããã¯ãåæéºäŒé åãå«ã人工ã¿ã³ãã¯è³ªã§ãããèšãæããã°åæçç©åŠã§ããããã®äººå·¥çãªéºäŒåé åãã¡ãã»ã³ãžã£ãŒRNAã§ãã
SEQ ID No:1ã¯ããVACCINEãç¹èš±çªå·20130216569ã§ãã

SEQ ID NO: 1 ç¹èš±çªå·20130216569ã«ã¯ã以äžã®èŽåœçãªåè«å¯çç åäœïŒToxoplasma GondiiãEimeriaãPlasmodiumãTheileriaãå«ãŸããŠãããšæç€ºãããŠããŸãã

SEQ ID NO: 2ã¯Boston Biomedical Research InstituteãææããNIHããããã£ãŠAnthony Fauciããå€é¡ã®è³éæäŸãåããŠããŸããSEQ ID NO: 2ã¯ãŸããåºä¹³é¡ã«ããããèã®çåºããæšçãšãããããé²ãããã«èšèšãããåæmRNAã¿ã³ãã¯è³ªã§ãããåèãŸã§ã«ãããã¯åºä¹³é¡ã«åé¡ãããã

å粟åµãéïŒéæåž¯ïŒããå¥ãããåå®®å èã«ä»çã»åºå®ãããåå®®å çºè²ãéå§ããç¬éãçåºã§ããå粟åµã®çåºã¯ãå粟åŸ5ã6æ¥ã®éã«èµ·ãããæ¬è³ªçã«ãSEQ ID NO: 1ã¯ãåèã®æåã®æ°æ¥ä»¥å ã«èã®çºéãäžæ¢ãããã
SEQ ID NO: 1ã¯ãPfizerãModernaãNovavaxãJanssenïŒJ&JïŒãOxfordãªã©ã®ãCOVID jabç¹èš±å ã§èŠåºãããšãã§ãããSEQ ID NO: 2ã¯ãModernaãPfizerããã³Novavaxããã³ãã®ä»ã«èŠåºãããã
âPFIZER
ãã¡ã€ã¶ãŒã³ãããŠã£ã«ã¹ã¯ã¯ãã³ç¹èš±ïŒWO2021213945A1ã¯ãSEQ ID NO: 1ãšSEQ ID NO: 2ã®äž¡æ¹ãå«ã¿ãèŽåœçãªåè«ã®å¯çãšã€ã³ãã©ãŒã ãã³ã³ã»ã³ããªãã®ããŒã¹ã³ã³ãããŒã«ãè¡ããŸãã

âã¢ãã«ã
Moderna Sars-cov-2 mRNA Domain Vaccines ç¹èš±çªå·WO2021159040A2ã«ã¯ãSEQ ID NO: 2ã®ããŒã¹ã³ã³ãããŒã«ãã€ã³ãã©ãŒã ãã³ã³ã»ã³ããªãã«å«ãŸããŠããŸãã

Moderna Delivery and Formulation of Engineered Nuclei Acids Vaccine Patent #US10898574B2 contains SEQ ID NO: 1, with deadly protozoan parasites without Informed ConsentïŒã€ã³ãã©ãŒã ãã³ã³ã»ã³ããªãã«ãèŽåœçãªåè«ã®å¯çãå«ãïŒã

âNOVAVAX
ããããã¯ã¹ã³ãããŠã€ã«ã¹ã¯ã¯ãã³è£œå€ç¹èš±çªå·US20210228709A1 SEQ ID NO:1ãšSEQ ID NO:2ã®äž¡æ¹ãå«ãŸããŠãããã äž¡æ¹ã®åºç£ å¶åŸ¡ãšèŽåœç åè«å¯çè« ã€ã³ãã©ãŒã ãã³ã³ã»ã³ããªãã


âJANSSENïŒJ&J瀟ïŒ
Janssen (J&J) ã³ãããŠã€ã«ã¹ææã®äºé²ããã³æ²»çã®ããã®çµæç©ããã³æ¹æ³-SARS-Cov-2ã¯ã¯ãã³ ç¹èš±çªå·WO2021155323A1ã«ã¯ãSEQ ID NO: 1ãèŽåœçãªåè«ã®å¯çã§å«ãŸããŠããŸãã

âãªãã¯ã¹ãã©ãŒã
Oxford Compositions and Methods For Inducing An Immune Response Vaccine ç¹èš±çªå·WO2021181100A1ã«ã¯ãSEQ ID NO: 1ãèŽåœçãªåè«ã®å¯çã§å«ãã§ããŸãã

mRNAãã¯ã¿ãŒãšããŠã®å¯çè«
ãã®BMCã®ç ç©¶ã¯ãèŽåœçãªå¯çè«ã2018幎ã«ãäžçä¿å¥æ©é¢ã«ãã£ãŠã¡ãã»ã³ãžã£ãŒRNAãã£ãªã¢ãšããŠæ¬åœã«éçºãããããšãæ€èšŒããŠããŸããç¹ã«5ã€ã®ãã©ãªã¢åè«ã®äžã§æãèŽåœçãªãPlasmodium falciparumãToxoplasma gondiiãTrypanosoma cruziãPlasmodiumå±ã¯ãåºä¹³é¡ïŒããïŒçްèã§ã®ã¯ã¯ãã³ã®ããã®mRNAãã¯ã¿ãŒèŒžåºãšããŠèšåãããŠããŸãã
ãã®ã€ã©ã¹ãã¯ãéºäŒåçµã¿æãå¯çè«ã®mRNAãã¯ã¿ãŒãè¶è²ã®ããããããã®ç·ã§æãããäžžãé ãã€ããŠããŸããå¯çè«ã«ä»çããŠãããã®ãšãå¯çè«ã®å°»å°Ÿã«ããã³ã€ã«ããéºäŒåé åã衚ããŠããã®ãããããŸãããã®ã°ã©ãã¯ãå¯çè«ãç Žè£ãã穎ãã现èèã«å ¥ããçŽ°èæ žã«å°éããŠmRNAãéã蟌ã¿ã现èã®DNAã«éºäŒçå€åãäžããæ§åãæŠèª¬ããŠããã

BMCNIHã®ãµã€ãã«ãããšhttps://pubmed.ncbi.nlm.nih.gov/21976603/
"ã·ã£ãŒã¬ã¹ç ã¯ãåççç©ã§ããããªãããœãŒãã»ã¯ã«ãŒãžã«ãã£ãŠåŒãèµ·ããããå¿èãæ¶å管ã«çåœãè ããå¯èœæ§ã®ããçŸæ£ãåŒãèµ·ãããŸãã"
COVIDã®æ¥çš®ã§å¿èãã¯ããèèãèç€ã女æ§ã®çæ®åšãªã©ã®éèŠãªèåšã«å¯çæ»æãèªçºïŒå¿ççããšãã蚺æãå®ã¯CHAGASãªã®ãïŒ
äžã®åçã¯ããããŒãã»ã€ã³ã°å士ãæè¿æ®åœ±ããã圌ã®ã¯ã©ã€ã¢ã³ãã®äžäººã®äººéã®çްèã«å¯çè«ãèå»¶ããŠããããšã瀺ãå®éšåçã§ããã

ãããŒãã»ã€ã³ã°å士ã®äœåã¯ãã¡ãããã芧ããã ããŸãã
https://www.drrobertyoung.com/
ã¢ãªã€ãã»ã©ãå士ã®ãã¬ã°ã©ã ãã£ã³ãã«ã¯ãã¡ããããã©ããŒã§ããŸãã
https://t.me/DrAriyanaLove
ãã®çç©åŠçæ»æã«å¯ŸããŠãã©ã®ããã«ãããã¯ã¹ããå
ç«ã·ã¹ãã ã匷åãããã«ã€ããŠã¯ããã¡ãããã©ãå士ã®ã³ã³ãµã«ããŒã·ã§ã³ãäºçŽããããšãã§ããŸãã
https://calendly.com/drloveasea/
ã©ãå士ã®ç ç©¶ãžã®å¯ä»ããæ€èšãã ããã
https://www.givesendgo.com/metanutrients
é¢é£èšäº
1   COVID-19ã®ãã³ãããã¯ã¯ãSARS-CoV-2ãŠã€ã«ã¹ããã®äºçš®ã«ãã£ãŠåŒãèµ·ãããããã®ã§ã¯ãªãã
COVID-19ã¯æ°çš®ã®Aiçç©å
µåšã§ãããäžéšã¯ãã¯ãããžãŒãäžéšã¯çç©åŠã§ããããããŠããã¯ç¥çã§ããã